Literature DB >> 4621265

Cyclophosphamide: use in practice.

M E Gershwin, E J Goetzl, A D Steinberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4621265     DOI: 10.7326/0003-4819-80-4-531

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  37 in total

Review 1.  Cyclophosphamide toxicity. Characterising and avoiding the problem.

Authors:  L H Fraiser; S Kanekal; J P Kehrer
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  Cutting-edge issues in organ-specific autoimmunity.

Authors:  M Eric Gershwin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

3.  Immunological reactivity of the lung. IV. Effect of cyclophosphamide on alveolar macrophage cytotoxic effector function.

Authors:  G W Hunninghake; A S Fauci
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

4.  Protective and immunostimulating activity of a low dose of cyclophosphamide in the experimental infection of mice with foot-and-mouth disease virus.

Authors:  E L Portiansky; W M DiGirolamo; R P Laguens
Journal:  Experientia       Date:  1989-01-15

5.  Reduced natural cytotoxic cell activity in patients receiving cisplatin-based chemotherapy and in mice treated with cisplatin.

Authors:  C B Powell; D G Mutch; M S Kao; J L Collins
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

6.  In Vivo Growing of New Cell Colonies in a Portion of Bone Marrow: Potential Use for Indirect Cell Therapy.

Authors:  Ana Manzanedo; Fidel Rodriguez; Jose A Obeso; Manuel Rodriguez
Journal:  Cell Med       Date:  2010-11-05

7.  Quantitative and qualitative effects of cyclophosphamide administration on circulating polymorphonuclear leucocytes.

Authors:  G W Hunninghake; A S Fauci
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

8.  Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

9.  A comparative study of therapeutic activity, myelotoxicity and DNA damage in the bone marrow of mice after cyclophosphamide and ASTA Z 7557 (INN mafosfamide).

Authors:  M R Berger; P Bedford; W J Zeller; M Kaufmann
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

10.  Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.

Authors:  R J ten Berge; H K van Walbeek; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.